Bristol University biotech company runner-up in UK Trade & Investment awards
Press release issued: 19 July 2007
Apitope, a University of Bristol biotech spin-out company, wins UK Trade & Investment runner-up prize for innovation in drug discovery and development. The company makes treatments for allergies and autoimmune diseases such as multiple sclerosis.
The company, which makes treatments for allergies and autoimmune diseases such as multiple sclerosis, was selected as runner-up in the award category for innovation in drug discovery and development.
Apitope is developing a multiple-sclerosis therapy now undergoing clinical trials. It is also working on a MS diagnostic blood test and a vaccine to combat dangerous factor-VIII inhibitor antibodies in haemophilia A patients.
Dr Keith Martin, Apitope's chief executive says, ‘In the past year Apitope has had some remarkable achievements and we look forward to building on this rapid progress when we report the outcome of our clinical trial in MS patients later this year.’
Apitope operates out of the Bristol SETsquared Business Acceleration Centre. The Centre, one of five in the South and South West of England, is part of the SETsquared Partnership, an enterprise collaboration of the universities of Bath, Bristol, Southampton and Surrey. Together they support early-stage, high-tech, high-growth potential ventures from both within and outside the universities.
Lectus Therapeutics, another University of Bristol spin-out company, was a runner-up in the same category. Lectus focuses on next-generation ion-channel modulators for a range of illnesses including angina, asthma, epilepsy and urinary bladder disorders.
- Apitope aims to revolutionise the treatment of chronic autoimmune and allergic disorders. It has patented technology allowing the design of peptide therapeutics (ApitopesTM ) for these diseases.
- UK Trade & Investment is the UK government’s international business development organisation.
- For more information contact Sadia Haq, tel: 0117 928 8676, email: firstname.lastname@example.org or Dr Keith Martin, tel: 0117 903 1119, email: email@example.com.